Status:
UNKNOWN
Validation of the Consecutive-Letter Substitution Task (CST)
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-75 years
Brief Summary
The CST is a new neuropsychological test created to measure information processing speed, which is frequently impaired in patients with multiple sclerosis. The aim of the study is to validate the CST ...
Detailed Description
STUDY DESIGN: This is a monocentric, observational study with low-risk intervention. STUDY PROCEDURES: The CST consists of a standard A4 sheet of paper that shows 135 items within a table of nine row...
Eligibility Criteria
Inclusion
- Italian native speaker;
- No neurological and/or psychiatric diseases;
- Willing and able to comply with study procedures.
Exclusion
- History of drug, alcohol or substance abuse;
- A score \> 9 on the Montgomery-Åsberg Depression Rating Scale (MADRS), which is the lower limit for mild depressive symptoms;
- Any person unable to understand and follow the instructions of the investigators.
Key Trial Info
Start Date :
January 3 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT06066281
Start Date
January 3 2023
End Date
November 30 2024
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy, 20132